MedPath

A Study of Non-invasive Measurement of Blood Glucose and Blood Pressure

Not Applicable
Completed
Conditions
Diabetes
Interventions
Device: LIFELEAF Smartwatch
Registration Number
NCT05904769
Lead Sponsor
Mayo Clinic
Brief Summary

The purpose of this research is to compare blood glucose, blood pressure and electrocardiogram (ECG) readings on the LIFELEAF Smartwatch compared to standard methods of measurement.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
87
Inclusion Criteria
  • Diabetic patients on insulin undergoing four times daily blood sugar checks as part of standard of care.
  • Patients undergoing continuous monitoring for heart rate and blood pressure as part of their routine care.
  • Patients undergoing catheter ablation for atrial fibrillation.
Read More
Exclusion Criteria
  • Patients unable to provide informed consent.
  • Patients without arms as these are needed to wear the wrist-based sensor.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Electrophysiologic (EP) GroupLIFELEAF SmartwatchSubjects undergoing an EP procedure will wear he LIFELEAF Smartwatch for the duration of the procedure.
Hospitalized Diabetic GroupLIFELEAF SmartwatchSubjects hospitalized and diabetic on insulin, undergoing four times daily blood sugar checks, will wear the LIFELEAF Smartwatch for the duration of their hospital stay.
Primary Outcome Measures
NameTimeMethod
Systolic blood pressureBaseline

Measured in millimeters of mercury (mmHg)

Diastolic blood pressureBaseline

Measured in millimeters of mercury (mmHg)

Blood glucose levelBaseline

Measured in milligrams per deciliter (mg/dL)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic Minnesota

🇺🇸

Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath